The advertisement promotes a drug developed by CU Anschutz researchers that shows potential in restoring vision for individuals affected by multiple sclerosis and other neurological conditions.
Creative Information
| CID: | 12964886-14b7-4e1b-aa9f-1254943e4cac |
| CRID: | 2_151_1212493 |
| Domain: | cuanschutz.edu |
| Seat: | BSW |
| Size: | 300x250 |
| Bid: | $0.46 |
| Timestamp: | 11/26/2025, 4:43:27 PM |
| Declared IAB Categories: |
Analysis
5 succeeded(100% complete)
| Task | Status | Last Updated | Duration | Actions |
|---|---|---|---|---|
| ad_analysis | success | 12/10/2025, 4:25:53 AM | 4.77s | |
| adomain_analysis | success | 11/26/2025, 5:48:26 PM | 3.12s | |
| adomain_capture | success | 11/26/2025, 5:48:23 PM | 0.19s | |
| ad_render | success | 12/10/2025, 4:25:48 AM | 16.07s | |
| brand_mapping | success | 11/26/2025, 4:43:28 PM | 0.14s | |
Analysis Results
Ad Format: banner
Brands: CU Anschutz
| Size: | 300x250 | ||||||||||||||||||||||
| Data Transferred: | 999.41 KB | ||||||||||||||||||||||
| Render Time: | 7.22 Seconds | ||||||||||||||||||||||
| Creative Inferred IAB Categories: |
| ||||||||||||||||||||||
| Creative Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Domain Inferred IAB Categories: |
| ||||||||||||||||||||||
| Domain Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Total Ad Size: | 1000.17 KB | ||||||||||||||||||||||
| Requests Made: |
|
Advertiser Domain
Ad Preview
Raw Ad Markup
<div class='bidtellect-native-ad' data-pid='1818470678'><style type="text/css">
@import url('https://fonts.googleapis.com/css?family=Montserrat:400,500,700|Roboto:300,400,500,700&display=swap');
#bt-300x250,#bt-300x250 *{margin:0;padding:0;top:auto;right:auto;bottom:auto;left:auto;line-height:1.1;text-align:left;white-space:normal;word-wrap:normal;word-break:normal;outline:none;box-sizing:border-box;text-decoration:none;color:#000;font-family:'Montserrat',sans-serif;font-weight:400;font-size:9px;}#bt-300x250{width:300px;height:250px;display:block;position:relative;overflow:hidden;cursor:pointer;background-color:#fff;}
#bt-300x250 .bt-img{width:300px;height:157px;display:block;}#bt-300x250 .bt-wrapper{width: 100%;height: 93px;display: table;}#bt-300x250 .bt-text-wrapper{padding:0 7px;height: auto;display: table-cell;vertical-align: middle;}#bt-300x250 .bt-short-text{font-size:12px;padding:8px 0 6px;font-weight:500;font-family:'Roboto',sans-serif;}#bt-300x250 .bt-sponsored{text-transform:uppercase;}#bt-300x250 .bt-long-text{line-height:1.2;}
</style>
<div id="bt-300x250"><a href="https://bttrack.com/Click/Native?data=BlVAlEF-VXiuclJze-9q37vLdNz_gQuSKUFoq8pjJULlL0s7bllqVFWjGgzZjRAr_ByfVHMSJeYGTMaMjMymRawnDCxlpowszGWnJwZGJaamBwZMhqYG5oxsZqATTw24AAdPzsEvTgASgE1wACjG1cACNKiNZ4zgAv_zBgYoAtDo6OB0Xl7u7u5cwtzI5N7SyMLq6NDe5NLo8lzG3tpe5t7c8lru0FpiYGBg8NpsWtDKwsjg0N7cyuZayMrC2FpmbGJyYmRsAObGOpFnA6F-ToLGOHNzQuMjU0LjQuMTI1ALwAAAM1e0w8VwhWFk2NDI3NmpyMnBwRVJTWW9sTVRmSmxWQUtldFg3TGR2ZXN1aGFkRDNxUHZaTmxrWQAIN0ZGlkALGzGxgZnLMbFrMwspyWmhwbMxaxGhsalrMYGJkYmDGYmpibnAAurmATgwMjE5AKgogMFgYDggwDCASPAAADDkwIZADy_Xnqk3olAAAAAAAAAAAEoACAAjAV4AAB_mDA0hppXjApzC6NLsygDEbxZDEFhgVQI0" target="_blank"><img class="bt-img" src="https://cdn.bttrack.com/licrop/300/157/334042" width="300" height="157" alt=""><div class="bt-wrapper"><div class="bt-text-wrapper"><div class="bt-sponsored">Sponsored By: The CU Anschutz Medical Campus</div><div class="bt-short-text">Drug Shows Promise in Restoring Vision Lost to Nerve Damage</div><div class="bt-long-text">CU Anschutz researchers have identified a drug that could restore vision in individuals with multiple sclerosis and other neurological conditions.</div></div></div></a></div><div style="display:none;"><div style="display:none;"><img src="https://ghent-gce-sc.bidswitch.net/imp/0.4612/BSWhttps_A_B_Bbttrack.com_BPixel_BImpression_B_Cdata_RBlVA7XUshat2AR6D7aShCgsp-TWtkC-SKUFoq8pjJULlL0s7bllqVFWjGgzZjRAr__ByfVHMSJeYGTMaMjMymRawnDCxlpowszGWnJwZGJaamBwZMhqYG5oxsZqATTw24AAdPzsEvTgASgE1wACjG1cACNKiNZ4zgAv__zBgYoCtDo6OB0Xl7u7u5cwtzI5N7SyMLq6NDe5NLo8lzG3tpe5t7c8lru0FpiYGBg8NpsWtDKwsjg0N7cyuZayMrC2FpmbGJyYmRsAObGOpFnA6F-ToLGOHNzQuMjU0LjQuMTI1ALwAAAM1e0w8VwjWFk2NDI3NmpyMnBwRVJTWW9sTVRmSmxWQUtldFg3TGR2ZXN1aGFkRDNxUHZaTmxrWQAIN0ZGlkALGzGxgZnLMbFrMwspyWmhwbMxaxGhsalrMYGJkYmDGYmpibnAAurmATgwMjE5AKgogMFgYDgg4qIgKSAABSgAEggUUAACjAAJCAAAAAAAAASaBQAAAKKAAlICgAAAUoACHPITnSGDn2xHaRwAB9ODC7nPfikByB-kggNC7nPfikByB-kggMGEAkeAAEAAAAQAAAAGHJgQyAHl-vPVJvRKAAAAAAAAAIAAAAQAAABAAAAABKAAgQ5532gPQc7cHBlsjD4EYCvAAAP8wYGkNNK8YAA0_Jtype_Rimg_Jprice_R_I_WAUCTION__PRICE_X/nDFVMJROqHgX2kEy8_EjbW6haKXOYSczKdr3m3QayURsFIxlEkMCjdGnhuWj6NDmLtrnoSWHw68znbWs6XkkwZ6j673I4j8yNGxMGVy9PAdmQap9sRJHfd5hk2t4PfPkpAy-LMQUDfIDwCZDcK2YCAu293GJ41FEId_ugekvakOXEof1rT8efGNONA08pOSIZcu4UWT1Yno3jhsOan7kacWIFMjLYAm4Mn7S0UibSiRHjVdyHxUY5fk3c58ASugH8KHZ9LHP5MSwdMm2DbujzBiJPVl2DK7JA3Kj1hL-QQ9RnM5VgBTqr6rSLUnx7hJEDYJF6Mce9yCO7URcHHnu57EzP_7FMKmeq_Vy6F11o921Mx4I9ljTaGn0nfaOSqNG5UO76d6tZNRactZ0FGlKqH53kDN0707IFfiOMv8ceV6Dj6hi0Ha9RYekEapJHCzEtGKnhnQXf6zSL9aGENCHo9xrFcqjj-wm-LhANQWhFts9DaJFCEg1d7ohfO4gMe940mQO7ueHqcSzFWtRP_6osxz9LytnnXGMC7D94yp02-P0hTJQg_vHmYIsYyOz2tYw2wYPPhpWc59YwMrE_CX1yRDYbaQmLF_gj57A-_RVoT-SIW9BzknWhTRccSwN5Ufdj8-PcwlbgWDfA0bWKYEuILoGo7wyPVrj_fh5Imy124gB5hyDc3ID8GlrslxUSRB7tEnXuvkD9rmu7sYPAK0sMqOeCdEEg83GBx1doTdUSNwR3d5Ew_7IGbvtq0oZ-5zEOiQUwC1-iAOCuy2RPc6gmUeIWhvEiI4Twy5Erpr_UXs1eK8ld_NWjbnu7bvO8bRGvTFuiEIUu5-lr4rUVgQyOF9zaFewrP73gWtBBKwI_Xl7rF_Q7pGdXT-exUAiK2loyEd6dw0gLL8sJDBpthHkvmK2SOfJpHohEwHoK7rSq3x9on_5ebHJ2y4qvDesFh_ULTtIw1_gPrzyR3rgcsdbf4Lx1Pl5YLiOP15ejkY1UFs733ffpbsE-sFxVnbdg87uOKbJEcIZwsfuo_rY88vlgJj64fa5HR6f4T3jii4ZxgdGrbVaUmie-Jyh2ijfbGtZODPbA1JPl7M6Hhr2uZuVSufh6GTenQYBqSUyPYjTqpM7I7tOR9h_QDiWhay4nu_GsW59XP7yS91ABYNuzWHrVE4E640rrgQ7FWSmdfsGVuPJ-HMe9eJZSLuwPzzs-1gxlh35PTh5jQSDGhkcO4L-PQQfQxUj-VR0DpES1cc_wxnHeBt39-mfKa8kJAV6a7CZDaO6hBm1Hj9PDlMo99Un61RUxOcntYm0MzKxcP4alMdCUMNNSCch1loSM8Kwxaxci7tikDMoa9Nc4wnxEHW5qH99CTnxFcUpDitWro3RUI45h8hoRwyTGQhVv-4ar_5-nqHKugHXWAy_f_lygTibFSm68TiHrm_x12Uy0gIhAphX5sqvmAlCjtFroTCodwpmxeQs9R9nvGO7xnY7d2xwjmylx7Uku_YVfKhTATg_YGB7aXUpKGj4Dwg7sxvcBaaxkxyFrf2MAyHB-hpvoYO3Brjgf7RjUS31OtB2yxkn3IVY4HjkhZCJsAya3EZni73Tj4F-O1-shxcn7wqCkp2Fiv2OScJyqM4zfZL4nMOqcDRbBRhFidckJH3LNpSdbXdzjHPWn7lpvfJuZQXF/" border="0" height="1" width="1" /><img src="https://ad.doubleclick.net/ddm/trackimp/N510001.3605447SIMPLIFI15/B33984179.427716493;dc_trk_aid=621449254;dc_trk_cid=240658070;ord=1764118291751;dc_lat=;dc_rdid=;tag_for_child_directed_treatment=;tfua=;gdpr=0;gdpr_consent=;gpp=${GPP_STRING_755};gpp_sid=${GPP_SID};ltd=;dc_tdv=1?" border="0" height="1" width="1" /><img src="https://bttrack.com/Pixel/DmpPixel/?data=BlVAadnnbbv11M5XNDTlUyEeDjP_-vqYGTMaMjMymRawnDCxlpowszGWnJwZGJaamBwZMhqYG5oxsZqATAxQCAA1&id=1&type=img" border="0" height="1" width="1" /><img src="https://bttrack.com/Pixel/DmpPixel/?data=BlVAadnnbbv11M5XNDTlUyEeDjP_-vqYGTMaMjMymRawnDCxlpowszGWnJwZGJaamBwZMhqYG5oxsZqATAxQCAA1&id=4&type=img" border="0" height="1" width="1" /><img src="https://bttrack.com/Pixel/cookiesync?source=309b29a3-0496-4336-b0e1-a39d111f6db0" border="0" height="1" width="1" /><img src="https://bttrack.com/Pixel/cookiesync?source=6B2595D5-CF4E-4298-A4AC-BCC34433EAAD" border="0" height="1" width="1" /></div></div><script src="https://pixel.adsafeprotected.com/rjss/st/2372038/89391996/skeleton.js" type="text/javascript"></script><script src="https://pixel.adsafeprotected.com/jload?anId=10214&chanId=1212493&placementId=1818470678&adsafe_par&impId=BlVAWTxu6ojCpbRf6Wzt800h4rGbI3GSKUFoq8pjJULlL0s7bllqVFWjGgzZjRAr_ByfVHMSJeYGTMaMjMymRawnDCxlpowszGWnJwZGJaamBwZMhqYG5oxsZqATTw24AAdPzsEvTgASgE1wACjG1cACNKiNZ4zgAv_zBgYoCObGOpFnA6F-ToLGOHNzQuMjU0LjQuMTI1ALwAAAM1e0w8VwhWFk2NDI3NmpyMnBwRVJTWW9sTVRmSmxWQUtldFg3TGR2ZXN1aGFkRDNxUHZaTmxrWQAIN0ZGlkALGzGxgZnLMbFrMwspyWmhwbMxaxGhsalrMYGJkYmDGYmpibnAAurmATgwMjE5AKgogMFgYDgggA1&uId=688c5651-6633-4034-aff0-727d51cc4897" type="text/javascript"></script></div><img src="https://us-east-sync.bidswitch.net/sync?ssp=kargo&dsp_id=151&imp=1" alt=" " style="display:none"/>Creatives
